arrow
J

John E. Wagner

University of Minnesota Medical School
H指数:95
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies

cGMP iPSC来源肌源性祖细胞产品的临床前质量、安全性和有效性研究,用于治疗肌营养不良。Mol. Ther.

2025-07-170
OAAI
Vaccination for Patients Receiving Dialysis
2024-03-016
OAAI
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
2023-09-015
PRE
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease
2023-08-017
OAAI
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy

免疫重建分析表明,使用Omidubicel移植后具有抗病毒保护作用: 一项3期子研究

2023-08-016
OAAI
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses

鼠CAR19 Tregs抑制急性移植物抗宿主病并维持移植物抗肿瘤反应

2022-09-0817
OA
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

异基因造血细胞移植中造血恢复,移植排斥,移植失败,移植功能不良和供体嵌合的标准化定义: 代表美国移植和细胞治疗学会的报告

2021-08-01103
OAAI
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation
2021-01-0111
OAAI